SNTI Stock Analysis: Buy, Sell, or Hold?
SNTI - Senti Biosciences, Inc. Common Stock
$0.96
0.05 (6.01%)
▲
5d:
-1.56%
30d:
-5.87%
90d:
-4.94%
BUY
HIGH Confidence
Analysis Updated: Jun 10, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When SNTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNTI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SNTI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SNTI is currently trading at $0.96, which is considered fair relative to its 30-day fair value range of $0.94 to $1.01.
Technical Outlook: Technically, SNTI is showing sideways momentum. Immediate support is located at $0.91, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.25 (+1071.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNTI is showing sideways momentum. Immediate support is located at $0.91, while resistance sits at $1.05. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.25 (+1071.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.94 -
$1.01
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 1071.8% below Wall St target ($11.25)
Trading Range Analysis
30-Day Trading Range
$0.94 -
$1.01
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.91
Resistance Level
$1.05
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.01
Wall Street Target
$11.25
(+1071.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 10, 2026 5:06 PM ET
Data refreshes hourly during market hours. Next update: 6:06 PM
Data refreshes hourly during market hours. Next update: 6:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 53 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$58 | 54 HOLD |
